Prostatakarzinom imitiert metastasiertes Bronchialkarzinom – Ein Fallbericht

Zusammenfassung

Es wird über den Fall eines PSA-negativen und lokal fortgeschrittenen azinären Prostatakarzinoms berichtet, das bei thyroid transcription factor-1 (TTF-1) Expression eine Metastase eines bereits behandelten Bronchialkarzinoms imitierte. Unseres Wissens ist ein TTF-1 positiv azinäres Prostatakarzinom bisher nur ein Mal in der Literatur dokumentiert. Die Bestimmung des Immunophänotyps des Karzinoms mit Napsin A, CK7 und CK20 in Kombination mit der Beurteilung des gesamten Krankheitsverhaltens waren für die definitive Diagnose eines primären Prostatakarzinoms entscheidend.

Abstract

A PSA-negative, advanced adenocarcinoma of the prostate is a rare finding. Expression of thyroid transcription factor-1 (TTF-1) in the tumour in combination with a previous medical history of lung adenocarcinoma could complicate the final diagnosis. To the best of our knowledge, we present the second case of a TTF-1-positive, acinar adenocarcinoma of the prostate.

We present the case of a 65-year-old male with surgically treated lung adenocarcinoma; 3 years later we diagnosed adenocarcinoma of the bladder and prostate. Although our initial assumption was that the patient had metastatic lung carcinoma in the bladder and prostate, a further immune histochemical analysis of the carcinoma with Napsin A, CK7 and CK20, along with the evaluation of the clinical manifestations, led us to the diagnosis of primary adenocarcinoma of the prostate.

Schlüsselwörter

PSA-negatives Prostatakarzinom - TTF-1 Expression - Bronchialkarzinom - Napsin A - CK7 - CK20

Key words

PSA-negative adenocarcinoma of the prostate - TTF-1 expression - lung adenocarcinoma - Napsin A - CK7 - CK20

• Literatur

• 1 Comperat E, Zhang F, Perrotin C. et al. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin. Mod Pathol 2005; 18: 1371-1376
• 2 Sarsık B, Karadenİz N, ŞİmŞİr A. et al. Acinar Adenocarcinoma of Prostate with Predominant TTF-1 Positive Intraductal Component. Turk J Path 2013; DOI: doi:10.5146/tjpath.2014.01253.
• 3 Turner BM, Cagle PT, Sainz IM. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med 2012; 136: 163-171
• 4 Kummar S, Fogarasi M, Canova A. Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br J Cancer 2002; 86: 1884-1887
• 5 Birtle AJ. Prostate specific antigen negative prostate cancer. Doctoral thesis. University of London: 2005 Im Internet http://discovery.ucl.ac.uk/1444634/
• 6 Partin AW, Carter HB, Chan DW. et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990; 143: 747-752
• 7 Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Pathol 2002; 26: 767-773
• 8 Bates AW, Baithun SI. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology 2000; 36: 32-40
• 9 Wang W, Epstein JI. Small Cell Carcinoma of the Prostate: A Morphologic and Immunohistochemical Study of 95 Cases. Am J Surg Pathol 2008; 32: 65-71
• 10 Lim TK, Teo C, Giron DM. et al. Thyroid transcription factor-1 may be expressed in ductal adenocarcinoma of the prostate: a potential pitfall. J Clin Pathol 2007 60: 941-943